842 related articles for article (PubMed ID: 9307863)
21. Antiphospholipid Syndrome and the Kidney.
Sciascia S; Baldovino S; Schreiber K; Solfietti L; Roccatello D
Semin Nephrol; 2015 Sep; 35(5):478-86. PubMed ID: 26573550
[TBL] [Abstract][Full Text] [Related]
22. Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients.
Sciascia S; Radin M; Cecchi I; Bertolaccini ML; Bertero MT; Rubini E; Vaccarino A; Bazzan M; Giachino O; Baldovino S; Rossi D; Mengozzi G; Roccatello D
Rheumatology (Oxford); 2021 Mar; 60(3):1106-1113. PubMed ID: 31840749
[TBL] [Abstract][Full Text] [Related]
23. Accuracy of anticardiolipin antibodies in identifying a history of thrombosis among patients with systemic lupus erythematosus.
Escalante A; Brey RL; Mitchell BD; Dreiner U
Am J Med; 1995 Jun; 98(6):559-65. PubMed ID: 7778571
[TBL] [Abstract][Full Text] [Related]
24. The prevalence of antibodies to anionic phospholipids in patients with the primary antiphospholipid syndrome, systemic lupus erythematosus and their relatives and spouses.
Radway-Bright EL; Ravirajan CT; Isenberg DA
Rheumatology (Oxford); 2000 Apr; 39(4):427-31. PubMed ID: 10817777
[TBL] [Abstract][Full Text] [Related]
25. Serum amyloid A in autoimmune thrombosis.
Sodin-Semrl S; Zigon P; Cucnik S; Kveder T; Blinc A; Tomsic M; Rozman B
Autoimmun Rev; 2006 Nov; 6(1):21-7. PubMed ID: 17110312
[TBL] [Abstract][Full Text] [Related]
26. [Risk of thrombosis with increased anticardiolipin antibodies].
Winckelmann G
Dtsch Med Wochenschr; 1997 Apr; 122(15):492-3. PubMed ID: 9147943
[No Abstract] [Full Text] [Related]
27. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
[TBL] [Abstract][Full Text] [Related]
28. The prevalence of anticardiolipin antibody in patients with systemic lupus erythematosus and its association with clinical manifestations.
Basiri Z; Gholyaf M; Faridnia M; Nadi E; Bairanvand M
Acta Med Iran; 2013; 51(1):35-40. PubMed ID: 23456582
[TBL] [Abstract][Full Text] [Related]
29. The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus.
Taraborelli M; Lazzaroni MG; Martinazzi N; Fredi M; Cavazzana I; Franceschini F; Tincani A
Reumatismo; 2016 Dec; 68(3):137-143. PubMed ID: 27981815
[TBL] [Abstract][Full Text] [Related]
30. High IgA antiphospholipid autoantibodies in healthy Sudanese explain the increased prevalence among Sudanese compared to Swedish systemic lupus erythematosus patients.
Elbagir S; Elshafie AI; Elagib EM; Mohammed NA; Aledrissy MI; Manivel VA; Pertsinidou E; Nur MA; Gunnarsson I; Svenungsson E; Rönnelid J
Lupus; 2020 Oct; 29(11):1412-1422. PubMed ID: 32741301
[TBL] [Abstract][Full Text] [Related]
31. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
Cabiedes J; Cabral AR; Alarcón-Segovia D
J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
[TBL] [Abstract][Full Text] [Related]
32. Sudden sensorineural hearing loss in patients with systemic lupus erythematosus or lupus-like syndromes and antiphospholipid antibodies.
Naarendorp M; Spiera H
J Rheumatol; 1998 Mar; 25(3):589-92. PubMed ID: 9517786
[TBL] [Abstract][Full Text] [Related]
33. Antiphospholipid antibodies in pediatric systemic lupus erythematosus.
Seaman DE; Londino AV; Kwoh CK; Medsger TA; Manzi S
Pediatrics; 1995 Dec; 96(6):1040-5. PubMed ID: 7491218
[TBL] [Abstract][Full Text] [Related]
34. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
[TBL] [Abstract][Full Text] [Related]
35. Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies.
Neville C; Rauch J; Kassis J; Chang ER; Joseph L; Le Comte M; Fortin PR
Thromb Haemost; 2003 Jul; 90(1):108-15. PubMed ID: 12876633
[TBL] [Abstract][Full Text] [Related]
36. Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders.
Brenner B; Tavori S; Lerner M; Tatarsky I; Lorber M
Isr J Med Sci; 1992 Jan; 28(1):9-15. PubMed ID: 1733904
[TBL] [Abstract][Full Text] [Related]
37. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
38. Influence of antiphospholipid antibody levels and type on thrombotic manifestations: results from the Serbian National Cohort Study.
Stojanovich L; Markovic O; Marisavljevic D; Elezovic I; Ilijevski N; Stanisavljevic N
Lupus; 2012 Mar; 21(3):338-45. PubMed ID: 21993381
[TBL] [Abstract][Full Text] [Related]
39. Apoptotic neutrophils and anticardiolipin antibodies.
Courtney PA; Crockard AD; McMillan SA; Cairns AP; Bell AL
Clin Exp Rheumatol; 2001; 19(4):476. PubMed ID: 11491511
[No Abstract] [Full Text] [Related]
40. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH
Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
